For all trials, subjects had a minimum HbA 1c of 7.0%, and there were no restrictions on body weight or body mass index (BMI)
As new-generation GLP-1 drugs promote higher rates of loss, clinicians want to ensure that the desire to shed pounds and see improvements such as better cardiovascular health are balanced with the very real risks that may come with the treatment
Rapid Results A highly structured program for clients who want stronger early momentum and accountability
Aftercare involves maintaining a balanced diet, staying active, and continuing to follow the guidance of our medical team
Leptin sensitivity, which improves on GLP-1 therapy, also declines after stopping treatment
Recent clinical success with peptide-based treatments, such as GLP-1 receptor agonists 111,112 , illustrates that supraphysiological doses of gut hormones are highly promising, and ghrelin exerts opposing effects on appetite and motivation compared to GLP-1 12,113115